Sigurd Kirk serves as Executive at BARR PHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, Sigurd Kirk has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on May 23, 2024 involved receiving (via award) 53,750 shares valued at $0.
Sigurd Kirk currently holds 53,750 shares of BARR PHARMACEUTICALS INC (BRL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Sigurd Kirk has been a net neutral trader of BRL stock. They have purchased $0 and sold $0 worth of shares.
Sigurd Kirk's most recent insider trade was on May 23, 2024, when they sold 53,750 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |